<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35076891</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>The rising of old foes: impact of lockdown periods on "non-SARS-CoV-2" viral respiratory and gastrointestinal infections.</ArticleTitle><Pagination><StartPage>519</StartPage><EndPage>524</EndPage><MedlinePgn>519-524</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-022-01756-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">During COVID-19-related public health non-pharmaceutical prevention measures, such as social distancing, lockdown periods and use of face masks, a decrease in viral respiratory and gastroenterological infections was observed worldwide. Following discontinuation of preventative measures, a potential increase of respective infections outside of their usual seasons was a matter of concern.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We aimed to illustrate annual distribution of confirmed viral infections between 2017 and 2021 based on 32,506 clinical samples in a German pediatric tertiary care center and to explore the impact of the COVID-19 pandemic on the epidemiology of these infections in children.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">While a decrease in overall viral infections was observed during the first and second lockdown period, an extraordinary increase in the number of viral respiratory infections, predominantly caused by human Rhino-/Enterovirus and respiratory syncytial virus (RSV), was observed after relaxation of preventive measures. Notably, Rhino-/Enterovirus infections increased 4-fold (2020 vs. 2019) and 16-fold (2021 vs. 2019). The occurrence of RSV was observed beginning from June to August 2021 and reached an all-time record with a 25- to 50-fold increase in numbers in September and October 2021 in relation to previous pre-pandemic years (2017-2019). In contrast, for non-respiratory viruses (i.e. Rota-/Norovirus), the effect on respective seasonal patterns was only minimal compared to previous years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The observed increase in respiratory infections in children is worrying and is already causing hospitals to become overburdened. Enhanced vigilance will be key to face clinical challenges due to these epidemiological changes in viral disease patterns in the months to come.</AbstractText><CopyrightInformation>© 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maison</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8731-4218</Identifier><AffiliationInfo><Affiliation>Department for Asthma and Allergy, Dr Von Hauner Children's Hospital, Ludwig Maximilians University, Lindwurmstr. 4, 80337, Munich, Germany. Nicole.maison@med.lmu.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Asthma- and Allergy Prevention (IAP), Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), Munich, Germany. Nicole.maison@med.lmu.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Lung Research (DZL), Munich, Germany. Nicole.maison@med.lmu.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peck</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department for Asthma and Allergy, Dr Von Hauner Children's Hospital, Ludwig Maximilians University, Lindwurmstr. 4, 80337, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Illi</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Asthma- and Allergy Prevention (IAP), Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Lung Research (DZL), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer-Buehn</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Dr Von Hauner Children's Hospital, LMU University Hospital, Ludwig Maximilians University, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Mutius</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department for Asthma and Allergy, Dr Von Hauner Children's Hospital, Ludwig Maximilians University, Lindwurmstr. 4, 80337, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Asthma- and Allergy Prevention (IAP), Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Lung Research (DZL), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hübner</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Dr Von Hauner Children's Hospital, LMU University Hospital, Ludwig Maximilians University, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Both</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Dr Von Hauner Children's Hospital, LMU University Hospital, Ludwig Maximilians University, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Impact</Keyword><Keyword MajorTopicYN="N">Lockdown</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">Rhinovirus</Keyword><Keyword MajorTopicYN="N">Viral infections</Keyword></KeywordList><CoiStatement>Nicole Maison, Ulrich von Both, Johannes Huebner, Ana Peck, Sabina Illi, Melanie Meyer-Buehn have no conflict of interest. Erika von Mutius received consulting fees and funding for the research project “Impact of COVID 19 pandemic on patients with asthma and wheeze” from OM Pharma S.A.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>25</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35076891</ArticleId><ArticleId IdType="pmc">PMC8787179</ArticleId><ArticleId IdType="doi">10.1007/s15010-022-01756-4</ArticleId><ArticleId IdType="pii">10.1007/s15010-022-01756-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huppertz HI, Kopp MV, Hübner J. Prävention von infektionen durch das influenza- und respiratorische synzytialvirus nach aufhebung der lockdown-Maßnahmen. Monatsschr Kinderheilkd. 2021 doi: 10.1007/s00112-021-01278-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00112-021-01278-7</ArticleId><ArticleId IdType="pmc">PMC8369864</ArticleId><ArticleId IdType="pubmed">34421128</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki TK. Circulation of influenza, RSV, and SARS-CoV-2: an uncertain season ahead. Lancet Respir. 2021 doi: 10.1016/S2213-2600(21)00364-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00364-7</ArticleId><ArticleId IdType="pmc">PMC8346240</ArticleId><ArticleId IdType="pubmed">34370976</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner D, Groendahl B, Puppe W, et al. High antibiotic prescription rates in hospitalized children with human metapneumovirus infection in comparison to RSV infection emphasize the value of point-of-care diagnostics. Infection. 2019;47:201–207. doi: 10.1007/s15010-018-1194-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-018-1194-5</ArticleId><ArticleId IdType="pmc">PMC7100084</ArticleId><ArticleId IdType="pubmed">30132249</ArticleId></ArticleIdList></Reference><Reference><Citation>John-Sebastian E, Chisha S, Ruopeng X, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. medRxiv. 2021 doi: 10.1101/2021.07.21.21260810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.21.21260810</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodjat P, Christensen PA, Subedi S, et al. The reemergence of seasonal respiratory viruses in Houston, Texas, after relaxing COVID-19 restrictions. Microbiol Spectr. 2021 doi: 10.1128/Spectrum.00430-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00430-21</ArticleId><ArticleId IdType="pmc">PMC8557899</ArticleId><ArticleId IdType="pubmed">34494861</ArticleId></ArticleIdList></Reference><Reference><Citation>Haapanen M, Renko M, Artama M, et al. The impact of the lockdown and the re-opening of schools and day cares on the epidemiology of SARS-CoV-2 and other respiratory infections in children—a nationwide register study in Finland. EClinicalMedicine. 2021;34:100807. doi: 10.1016/j.eclinm.2021.100807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100807</ArticleId><ArticleId IdType="pmc">PMC8007090</ArticleId><ArticleId IdType="pubmed">33817612</ArticleId></ArticleIdList></Reference><Reference><Citation>Delestrain C, Danis K, Hau I, et al. Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV. Pediatr Pulmonol. 2021 doi: 10.1002/ppul.25644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25644</ArticleId><ArticleId IdType="pmc">PMC8662089</ArticleId><ArticleId IdType="pubmed">34473914</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini R, et al. Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children &lt; 2 years during seasonal influenza peaks. Infection. 2019;47:595–601. doi: 10.1007/s15010-019-01287-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-019-01287-5</ArticleId><ArticleId IdType="pmc">PMC7100292</ArticleId><ArticleId IdType="pubmed">30798473</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliano P, Sellitto C, Conti V, et al. Characteristics of viral pneumonia in the COVID-19 era: an update. Infection. 2021;49:607–616. doi: 10.1007/s15010-021-01603-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01603-y</ArticleId><ArticleId IdType="pmc">PMC8006879</ArticleId><ArticleId IdType="pubmed">33782861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoch M, Vogel S, Kolberg L, et al. Weekly SARS-CoV-2 sentinel surveillance in primary schools, kindergartens, and nurseries, Germany, June–November 2020. Emerg Infect Dis. 2021;27:2192–2196. doi: 10.3201/eid2708.204859.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2708.204859</ArticleId><ArticleId IdType="pmc">PMC8314813</ArticleId><ArticleId IdType="pubmed">34087088</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappini E, et al. Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: a narrative review. Acta Paediatr. 2021;110:2529–2535. doi: 10.1111/apa.15949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15949</ArticleId><ArticleId IdType="pmc">PMC8222862</ArticleId><ArticleId IdType="pubmed">34028088</ArticleId></ArticleIdList></Reference><Reference><Citation>Megremis S, et al. Rhinovirus species-specific antibodies differentially reflect clinical outcomes in health and asthma. Am J Respir Crit Care Med. 2018;198:1490–1499. doi: 10.1164/rccm.201803-0575OC.PMID:30134114;PMCID:PMC7212800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201803-0575OC.PMID:30134114;PMCID:PMC7212800</ArticleId><ArticleId IdType="pmc">PMC7212800</ArticleId><ArticleId IdType="pubmed">30134114</ArticleId></ArticleIdList></Reference><Reference><Citation>Maison N, Herbrüggen H, Schaub B, et al. Impact of imposed social isolation and use of face masks on asthma course and mental health in pediatric and adult patients with recurrent wheeze and asthma. Allergy Asthma Clin Immunol. 2021;17:93. doi: 10.1186/s13223-021-00592-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13223-021-00592-9</ArticleId><ArticleId IdType="pmc">PMC8444172</ArticleId><ArticleId IdType="pubmed">34530911</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz-Muñoz I, Tamames-Gómez S, Castrodeza-Sanz J, et al. Social distancing, lockdown and the wide use of mask; a magic solution or a double-edged sword for respiratory viruses epidemiology? Vaccines. 2021;9(6):595. doi: 10.3390/vaccines9060595.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9060595</ArticleId><ArticleId IdType="pmc">PMC8228489</ArticleId><ArticleId IdType="pubmed">34205119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>